|
Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes
|
Nov 2016
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Relationship of different platelet response criteria and patient outcomes in a romiplostim myelodysplastic syndromes trial
|
Sep 2014
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
High-dose Romiplostim Accelerates Hematologic Recovery in Patients With Aplastic Anemia Refractory to Eltrombopag
|
Jul 2020
|
Leukemia
|
aplastic anemia
|
|
Myelodysplastic syndromes and the risk of cardiovascular disease in older adults: A SEER-medicare analysis
|
Dec 2019
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Impact of somatic mutations on response to lenalidomide in lower-risk non-del(5q) myelodysplastic syndromes patients
|
Jul 2020
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials
|
Oct 2016
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Letter to the Editor: Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality
|
Jul 2020
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes
|
Mar 2015
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes
|
May 2014
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood - a prospective study by EWOG-MDS.
|
Jun 2013
|
Leukemia
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
